Colgate-Palmolive (CL) delivered mixed results in Q2 FY2026 on revenue of $5.4B versus the $5.4B estimate (+4.9% YoY) and EPS of $0.99. The next Colgate-Palmolive (CL) earnings date is Oct 30, 2026. Below is the full Colgate-Palmolive earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Colgate-Palmolive (CL) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$5.4B vs $5.4B est
$0.99 vs $0.95 est
+4.5%
-1.9%
Mixed
Q2 FY2026
$5.3B vs $5.2B est
$0.97 vs $0.94 est
+2.9%
+0.0%
Beat
Q1 FY2026
$5.2B vs $5.1B est
$0.95 vs $0.91 est
+4.2%
+7.8%
Beat
Q4 FY2025
$5.1B vs $5.1B est
$0.91 vs $0.89 est
+2.4%
-2.0%
Mixed
Q3 FY2025
$5.1B vs $5.0B est
$0.92 vs $0.90 est
+2.6%
-0.6%
Mixed
Q2 FY2025
$4.9B vs $4.9B est
$0.91 vs $0.86 est
+6.3%
-1.9%
Mixed
Q1 FY2025
$4.9B vs $5.0B est
$0.91 vs $0.90 est
+1.1%
-4.2%
In line
Q4 FY2024
$5.0B vs $5.0B est
$0.91 vs $0.89 est
+2.2%
-4.0%
Mixed
What you'll find
Next Colgate-Palmolive (CL) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Colgate-Palmolive reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Colgate-Palmolive (CL)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Colgate-Palmolive's next earnings date?
Colgate-Palmolive's (CL) next scheduled earnings date is Oct 30, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Colgate-Palmolive (CL) beat or miss earnings?
In Q2 FY2026, Colgate-Palmolive (CL) posted mixed results — revenue of $5.4B versus the $5.4B estimate (+0.1% surprise) and EPS of $0.99 versus $0.95 expected (+4.5% surprise). Magnisto decodes every Colgate-Palmolive (CL) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Colgate-Palmolive beat earnings estimates?
Over its last 8 reported quarters, Colgate-Palmolive (CL) beat Wall Street EPS estimates 7 times, most recently a mixed result in Q3 FY2026. Magnisto tracks every Colgate-Palmolive (CL) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Colgate-Palmolive stock move after earnings?
Over its last 8 quarterly reports, Colgate-Palmolive (CL) moved an average of ±2.8% the day after earnings — ranging from -4.2% (Q1 FY2025) to +7.8% (Q1 FY2026). The stock rose after 1 of those 8 reports and fell after 6. Heading into its next report on Oct 30, 2026, options-implied volatility is pricing in a move of roughly ±9.6% (derived). Magnisto tracks the realized post-earnings move for every Colgate-Palmolive (CL) quarter alongside the beat/miss verdict — past moves don't predict the next one.
What is the forecast for Colgate-Palmolive (CL) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Colgate-Palmolive (CL), anchored to the current $91.95 share price, so you can weigh the bull, base and bear cases for Colgate-Palmolive side by side.
Is Colgate-Palmolive (CL) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Colgate-Palmolive fits your own thesis and risk profile. This is research, not investment advice.